Chemours Co. (CC)
Chemours (CC) Expected to Beat Earnings Estimates: Should You Buy?
Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Chemours (CC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Stocks Worth Buying After Recent Broker Ratings Upgrade
Broker rating upgrades and robust earnings growth forecasts put PENN, CC and LITE in the spotlight as three stocks to buy now.
Chemours (CC) Surges 6.1%: Is This an Indication of Further Gains?
Chemours (CC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Chemours (CC) Down 4.5% Since Last Earnings Report: Can It Rebound?
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
Trump's Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30
American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition, EV plant buildouts, and aerospace demand are pushing capital back into U.S.
Chemours Q1 Earnings Call Highlights
Chemours NYSE: CC said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in its Thermal & Specialized Solutions and Titanium Technologies segments, while Advanced Performance Materials continued to recover from an outage at the company's Washington Works facility.
Chemours' Q1 Earnings Surpass Estimates, Revenues Miss
CC posted a wider Q1 loss as lower volumes hurt key segments, but pricing gains and upbeat Q2 sales guidance supported EBITDA.
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Why I Just Became Even More Bullish On The Canton Network
The article analyzes the Canton Network and its CIP-0105 update, which incentivizes Super Validators to lock rewards, aligning interests with long-term network success. CIP-0105 could result in 20–32% of Canton Coin supply being locked over the long run, reducing circulating supply and disincentivizing opportunistic selling. Major financial institutions like Nasdaq, DTCC, and others serve as Super Validators, signaling strong institutional adoption and potential for network effects.
Chemours Sees Unusually Large Options Volume (NYSE:CC)
The Chemours Company (NYSE: CC - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 10,642 call options on the company. This is an increase of 182% compared to the typical volume of 3,771 call options. Chemours Stock Performance Shares of CC stock opened at $17.60 on Friday. Chemours has a
